Latest Diabetes: Type II news
Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors
posted March 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Nonarteritic Anterior Ischemic Optic Neuropathy Increased With Semaglutide
posted February 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Probability of Cardiovascular Events Lower in Type 1 Diabetes Versus Type 2
posted February 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
posted February 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
U.S. Adults May Not Understand Their Risk for Vascular Disease
Youth Suicide Risk Linked to Community Firearm Violence
150+ Minutes of Social Media Daily Tied to Depression in Adults
Therapist-Led Online Cognitive Behavioral Therapy Aids Depression
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes
Type 2 Diabetes Linked to Worse Menopausal Symptoms
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk